Vertigo & vestibular disorders Board decisions

The Board remands the claims for further development, including obtaining additional medical opinions to address secondary service connection and duty-to-assist errors.

The Board granted an effective date of November 25, 2015, for the assignment of an initial 60 percent disability rating for the service-connected ear disability.

The Board granted a separate 30 percent rating for vertigo, which is secondary to the Veteran's service-connected insomnia disorder with major depressive disorder.

The Veteran withdrew her appeals for service connection for adjustment disorder, insomnia, and vertigo.

The Board granted service connection for bilateral hearing loss, tinnitus, erectile dysfunction as secondary to PTSD with major depressive disorder, and hypertension as secondary to PTSD with major depressive disorder. It also granted a 100 percent rating for PTSD with major depressive disorder from May 1, 2023, and special monthly compensation (SMC) under 38 U.S.C. § 1114(s).

The Board granted a 40 percent rating for PTSD with TBI from March 12, 2020 to January 4, 2022 and denied an effective date earlier than January 5, 2022 for the 70 percent rating.

The Board granted an earlier effective date of October 27, 2019, for service connection of peripheral vestibular disorder (vertigo or dizziness), chronic prostatitis, chronic laryngitis, and erectile dysfunction.

The Board denied service connection for high cholesterol, TMJ, chronic neck pain, gallbladder removal, high blood pressure, inguinal hernia, chronic pain in both feet, left knee disability, and right knee disability as there was no evidence of a current disability or functional impairment that limits earning capacity.

The Board remands the claims for service connection for lower urinary tract symptoms, erectile dysfunction, vertigo, and psoriatic arthritis to correct pre-decisional errors in the VA examinations.

The Board denied service connection for vertigo, hypertension, a disability manifested by insomnia, left and right ankle disabilities, pes planus, plantar fasciitis, and GERD as there was no evidence of current disability during the appeal period.

The Board denied the veteran's claims for a higher rating and earlier effective date for migraine headaches, service connection for bilateral hearing loss, and service connection for vertigo.

The Veteran's claim for a compensable rating for bilateral hearing loss was denied, and the claims for service connection for various disabilities were remanded.

The Board granted a 30 percent rating for the Veteran's tension headaches and remanded claims for an increased rating in excess of 30 percent for tension headaches and service connection for peripheral vestibular disorder secondary to tinnitus.

The Board denied the veteran's claims for increased ratings and earlier effective dates, finding that the current disability ratings accurately reflect his conditions.

The Board denied a rating in excess of 20 percent for diabetes mellitus type 2 with erectile dysfunction and vertigo, but granted a separate 10 percent rating for vertigo associated with DM2. The Board also denied initial ratings in excess of 20 percent for right upper extremity and left upper extremity peripheral neuropathy.

The Board denied the veteran's claims for increased ratings and restoration of a higher rating for benign paroxysmal positional vertigo (BPPV) and hearing loss, finding that the evidence did not support a higher disability rating.

The Board remands the claims for service connection for arthritic pain of the bilateral lower and upper extremities, an eye condition, a low back condition, vertigo, and vitamin D deficiency due to inadequate medical opinions.

The Board granted the Veteran's appeal for service connection and an earlier effective date, awarding a 100% rating for acoustic schwannoma status post resection with vertigo and staggered gait to include right hemiplegia stroke and bilateral hearing loss.

The appeal concerning the propriety of the rating reductions for the Veteran's right distal fibula disability and tinea pedis was dismissed, while SMC based on the need for aid and attendance was granted prior to February 20, 2024.

The Board granted an effective date of January 24, 2020 for residuals, TBI with vertigo and a 20 percent initial rating.